KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Enterprise Value (2019 - 2025)

Ginkgo Bioworks Holdings' Enterprise Value history spans 7 years, with the latest figure at -$422.6 million for Q4 2025.

  • For Q4 2025, Enterprise Value rose 24.74% year-over-year to -$422.6 million; the TTM value through Dec 2025 reached -$422.6 million, up 24.74%, while the annual FY2025 figure was -$422.6 million, 24.74% up from the prior year.
  • Enterprise Value reached -$422.6 million in Q4 2025 per DNA's latest filing, down from -$111.1 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$111.1 million in Q3 2025 to a low of -$1.7 billion in Q3 2021.
  • Average Enterprise Value over 5 years is -$861.3 million, with a median of -$892.3 million recorded in 2023.
  • Peak YoY movement for Enterprise Value: plummeted 470.4% in 2022, then soared 81.98% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$1.5 billion in 2021, then grew by 11.57% to -$1.3 billion in 2022, then grew by 28.25% to -$944.1 million in 2023, then skyrocketed by 40.52% to -$561.6 million in 2024, then rose by 24.74% to -$422.6 million in 2025.
  • Per Business Quant, the three most recent readings for DNA's Enterprise Value are -$422.6 million (Q4 2025), -$111.1 million (Q3 2025), and -$203.6 million (Q2 2025).